GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » Debt-to-Asset

Moolec Science (Moolec Science) Debt-to-Asset : 0.39 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Moolec Science Debt-to-Asset?

Moolec Science's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.39 Mil. Moolec Science's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $5.95 Mil. Moolec Science's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $21.32 Mil. Moolec Science's debt to asset for the quarter that ended in Dec. 2023 was 0.39.


Moolec Science Debt-to-Asset Historical Data

The historical data trend for Moolec Science's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science Debt-to-Asset Chart

Moolec Science Annual Data
Trend Jun21 Jun22 Jun23
Debt-to-Asset
- - 0.11

Moolec Science Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.11 0.12 0.39

Competitive Comparison of Moolec Science's Debt-to-Asset

For the Biotechnology subindustry, Moolec Science's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moolec Science's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Moolec Science's Debt-to-Asset falls into.



Moolec Science Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Moolec Science's Debt-to-Asset for the fiscal year that ended in Jun. 2023 is calculated as

Moolec Science's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moolec Science  (NAS:MLEC) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Moolec Science Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Moolec Science's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Moolec Science (Moolec Science) Business Description

Traded in Other Exchanges
N/A
Address
17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system.